Vincze D, Farkas A S, Rudas L, Makra P, Csík N, Leprán I, Forster T, Csanády M, Papp J G, Varró A, Farkas A
Department of Anaesthesiology and Intensive Care, University of Szeged, Szeged, Hungary.
Br J Pharmacol. 2008 Jan;153(1):75-89. doi: 10.1038/sj.bjp.0707536. Epub 2007 Oct 29.
No information is available concerning the effects of anaesthetics in the most frequently used in vivo pro-arrhythmia model. Accordingly, in this study we examined the effect of pentobarbital, propofol or alpha-chloralose anaesthesia on the pro-arrhythmic activity of the class III anti-arrhythmic dofetilide in alpha(1)-adrenoceptor-stimulated rabbits.
Rabbits anaesthetized intravenously with pentobarbital, propofol or alpha-chloralose were infused simultaneously with the alpha(1)-adrenoceptor agonist phenylephrine (15 microg kg(-1) min(-1), i.v.) and dofetilide (0.04 mg kg(-1) min(-1), i.v.). The electrocardiographic QT interval, the T (peak)-T (end) interval and certain QT variability parameters were measured. The heart rate variability and the baroreflex sensitivity were utilized to assess the vagal nerve activity. The spectral power of the systolic arterial pressure was calculated in the frequency range 0.15-0.5 Hz to assess the sympathetic activity.
Pentobarbital considerably reduced, whereas propofol did not significantly affect the incidence of dofetilide-induced torsades de pointes (TdP) as compared with the results with alpha-chloralose (40% (P=0.011) and 70% (P=0.211) vs 100%, respectively). In additional experiments, neither doubling of the rate of the dofetilide infusion nor tripling of the rate of phenylephrine infusion elevated the incidence of TdP to the level seen with alpha-chloralose. None of the repolarization-related parameters predicted TdP. The indices of the parasympathetic and sympathetic activity were significantly depressed in the alpha-chloralose and propofol anaesthesia groups.
In rabbits, anaesthetics may affect drug-induced TdP genesis differently, which must be considered when results of different studies are compared.
关于麻醉药对最常用的体内致心律失常模型的影响尚无相关信息。因此,在本研究中,我们检测了戊巴比妥、丙泊酚或α-氯醛糖麻醉对α1肾上腺素受体刺激的家兔中III类抗心律失常药物多非利特的致心律失常活性的影响。
用戊巴比妥、丙泊酚或α-氯醛糖静脉麻醉的家兔,同时输注α1肾上腺素受体激动剂去氧肾上腺素(15μg·kg-1·min-1,静脉注射)和多非利特(0.04mg·kg-1·min-1,静脉注射)。测量心电图QT间期、T(峰)-T(末)间期及某些QT变异性参数。利用心率变异性和压力反射敏感性评估迷走神经活性。计算收缩期动脉压在0.15 - 0.5Hz频率范围内的频谱功率以评估交感神经活性。
与α-氯醛糖相比,戊巴比妥显著降低了多非利特诱导的尖端扭转型室性心动过速(TdP)的发生率,而丙泊酚未产生显著影响(分别为40%(P = 0.011)和70%(P = 0.211),相比之下α-氯醛糖组为100%)。在额外实验中,多非利特输注速率加倍或去氧肾上腺素输注速率增至三倍均未使TdP发生率升高至α-氯醛糖组的水平。没有任何复极相关参数可预测TdP。α-氯醛糖和丙泊酚麻醉组的副交感神经和交感神经活性指标均显著降低。
在家兔中,麻醉药可能对药物诱导的TdP发生有不同影响,在比较不同研究结果时必须考虑这一点。